Inflammatory Conditions Care Value Program

For seven years in a row, inflammatory conditions has been the #1 driver of drug spend. In 2015, the average cost per prescription for this therapy class was $3,035.95 and, if left unchecked, drug spend for this class will nearly double by 2018.

The Inflammatory Conditions Care Value ProgramSM will manage this class at the indication level, helping to increase competition and control costs while ensuring patients receive specialized care exclusively from the Accredo® specialty pharmacy.

Key Benefits

  • Management of treatment options by indication, rather than class, increases competition and better controls costs.
  • Minimizes your financial exposure if patients discontinue preferred inflammatory medications early.
  • Provides patients and physicians with access to comprehensive and clinically appropriate treatment options.
  • Offers assistance and education for patients from the Accredo® specialized care team in the Inflammatory Conditions Therapeutic Resource CenterSM, where patients achieve better outcomes and 8% higher adherence* to therapy.

Highlights

  • Indication-level management refines utilization by setting treatment preferences for each inflammatory condition, which enables management of drugs by condition and delivers greater cost control for plan sponsors.
  • Early discontinuation reimbursement offers up to $2,000 per 30-day prescription for the first three fills of preferred inflammatory medications.
  • Rigorous clinical documentation ensures the appropriate therapy option is filled and patients get the medications that they need.

For more information, or to enroll in the Inflammatory Conditions Care Value Program, please contact your account team.

*Optimal adherence is defined as 80% or more.